JNCC: Hejie academician team released the latest cancer data in China: Lung cancer is the most common and deadly cancer in China (repeated topic)

Cancer is a major public health problem and has become one of the most common causes of death in China
.

Cancer registries can be used to continuously and dynamically monitor cancer incidence and mortality

Cancer is a major public health problem and has become one of the most common causes of death in China

On February 27 , 2022 , Chinese Academy of Medical Sciences / Peking Union Medical College / National Cancer Research Center He Jie and Wei Wenqiang published an online article entitled "Cancer incidence and mortality in China, 2016" in the Journal of the National Cancer Center.
The research paper, which underwent data quality control, qualified data from 487 cancer registries for inclusion in this analysis, 200 from rural areas and 287 from urban areas .
At the end of 2016 , the population covered by these cancer registries was 381,565,422 (193,632,323 males and 187,933,099 females ), representing 27.

The study found that in 2016 , there were about 4.
064 million new cancer cases and 2.
4135 million new cancer deaths in China

ASIR in men has been relatively stable over the past few decades , but women's overall cancer portfolio has increased significantly by about 2.
3% per year

In conclusion, cancer remains a major public health problem in China and requires long-term cooperation from the wider community

Cancer is a major public health problem and has become one of the most common causes of death in China
.

Cancer registries can be used to continuously and dynamically monitor cancer incidence and mortality

Cancer is a major public health problem and has become one of the most common causes of death in China

This report provides the latest statistics on the incidence and mortality of new cancers in China in 2016 , and provides a comprehensive estimate of the number of new cancer cases and deaths in 2016 .
The study further updated cancer incidence and mortality trends from 2000 to 2016 .
To date, the national cancer profile can provide a scientific basis for cancer prevention and control in China .
prevention

After data quality control, data from 487 cancer registries were eligible for inclusion in this analysis, 200 from rural areas and 287 from urban areas
.

At the end of 2016 , the population covered by these cancer registries was 381,565,422 (193,632,323 males and 187,933,099 females ), representing 27.
60% of the national population ( 24.
3% in urban areas and 32.
0% in rural areas ) .

After data quality control, data from 487 cancer registries were eligible for inclusion in this analysis, 200 from rural areas and 287 from urban areas

Estimated New Cancer Cases and Cancer Incidence Estimated New Cancer Cases and Cancer Incidence

Overall, the estimated number of new cancer cases in 2016 was 4,064,000 .

For men, lung cancer is the most common cancer, accounting for about 24.

Overall, the estimated number of new cancer cases in 2016 was 4,064,000 .
For men, lung cancer is the most common cancer, accounting for about 24.
6% of cancers in men ( 549,800 cases), followed by liver, stomach, colorectal, and esophageal cancers, which account for about 50% of all new cancer diagnoses in men .
68.

The age-standardized incidence rate (ASIR) of all cancers was higher in urban areas than in rural areas ( 189.
7/100,000 vs.
176.
2/100,000 )

Estimated Cancer Deaths and Cancer Mortality Estimated Cancer Deaths and Cancer Mortality

About 2,413,500 people died of cancer in China in 2016 .
Lung cancer is the most common cause of cancer death in both men and women .
Among men, lung cancer accounted for about 29.
71% ( 454,700 ) of all cancer deaths , followed by liver, stomach, esophagus, and colorectal cancers, which accounted for 75.
87% of cancer deaths in men .
For women, lung cancer was the most common cause of cancer death, followed by stomach, liver, colorectal and breast cancers, which accounted for 60.
06% of cancer deaths in women .

About 2,413,500 people died of cancer in China in 2016 .
Lung cancer is the most common cause of cancer death in both men and women .
Among men, lung cancer accounted for about 29.
71% ( 454,700 ) of all cancer deaths , followed by liver, stomach, esophagus, and colorectal cancers, which accounted for 75.
87% of cancer deaths in men .
For women, lung cancer was the most common cause of cancer death, followed by stomach, liver, colorectal and breast cancers, which accounted for 60.
06% of cancer deaths in women .

Age-standardized mortality ( ASMR ) for all cancers was higher in rural areas than in urban areas ( 106.
1/100,000 vs.
102.
8/100,000 )
.
Central China had the highest cancer mortality rate ( 112.
0/100,000 ), followed by Northeast and South China
.
North China ( 94.
5/100,000 ) had the lowest mortality rate
.
The mortality rate of colorectal cancer, lung cancer, female breast cancer, prostate cancer, kidney cancer, bladder cancer, lymphoma and leukemia in urban areas is higher than that in rural areas, while the mortality rates of digestive system such as esophagus and stomach cancer are higher in rural areas.
And there are more liver cancers than in urban areas .
 

Age-standardized mortality ( ASMR ) for all cancers was higher in rural areas than in urban areas ( 106.
1/100,000 vs.
102.
8/100,000 )
.
Central China had the highest cancer mortality rate ( 112.
0/100,000 ), followed by Northeast and South China
.
North China ( 94.
5/100,000 ) had the lowest mortality rate
.
The mortality rate of colorectal cancer, lung cancer, female breast cancer, prostate cancer, kidney cancer, bladder cancer, lymphoma and leukemia in urban areas is higher than that in rural areas, while the mortality rate of digestive system such as esophagus and stomach cancer is higher in rural areas.
Tumor leukemia digestion , and liver cancer more than in urban areas .
 

Age-category morbidity and mortality

age category morbidity and mortality age category morbidity and mortality

Cancer incidence and mortality both increase with age and peak in the 80-84 and 85+ age groups, respectively
.
The 60-64 and 50-54 age groups had the most cancer cases in men and women, while the 60-64 and 75-79 age groups had the most cancer deaths
.
Overall, men have higher morbidity and mortality rates than women, but women in the 20-49 age group have a higher incidence than men
.
 

Cancer incidence and mortality both increase with age and peak in the 80-84 and 85+ age groups, respectively
.
The 60-64 and 50-54 age groups had the most cancer cases in men and women, while the 60-64 and 75-79 age groups had the most cancer deaths
.
Overall, men have higher morbidity and mortality rates than women, but women in the 20-49 age group have a higher incidence than men
.
 

Estimated new cancer cases and deaths by age group and gender

Estimated new cancer cases and deaths by age group and gender Estimated new cancer cases and deaths by age group and gender

The 60-79 age group had the most cancer cases, with 1.
22 million men and 763,000 women , respectively .
Leukemia, brain tumors and lymphomas were listed as the three cancer types with the highest incidence in both men and women .
Lung cancer is the most common cancer incidence in men aged 45 years and older .
Breast cancer and lung cancer are the most common cancers in women aged 15-59 and over 60 , respectively .

The 60-79 age group had the most cancer cases, with 1.
22 million men and 763,000 women , respectively .
Leukemia, brain tumors and lymphomas were listed as the three cancer types with the highest incidence in both men and women .
Lung cancer is the most common cancer incidence in men aged 45 years and older .
Breast cancer and lung cancer are the most common cancers in women aged 15-59 and over 60 , respectively .

The 60-79 age group had the highest number of cancer deaths in both men and women .
Leukemia, brain cancer, lymphoma, and liver and bone cancers are the five deadliest cancers in both men and women .
Liver cancer is the leading cause of death in men aged 15-59 , and lung cancer is the most common cancer in men aged 60 and older; in women, breast cancer causes the most cancer deaths in the 15-44 age group, and Lung cancer accounts for the majority of cancer patients aged 45 years or older .

The 60-79 age group had the highest number of cancer deaths in both men and women .
Leukemia, brain cancer, lymphoma, and liver and bone cancers are the five deadliest cancers in both men and women .
Liver cancer is the leading cause of death in men aged 15-59 , and lung cancer is the most common cancer in men aged 60 and older; in women, breast cancer causes the most cancer deaths in the 15-44 age group, and Lung cancer accounts for the majority of cancer patients aged 45 years or older .

Trends in cancer incidence and mortality

Trends in Cancer Incidence and Mortality Trends in Cancer Incidence and Mortality

The age-standardized incidence rate for all cancers in men remained stable between 2000 and 2016 , but increased significantly by 2.
3% per year in women
.
Among men, the incidence of prostate cancer ( 7.
1% ), colorectal cancer ( 2.
4% ), leukemia ( 1.
9% ), brain cancer ( 1.
5% ), pancreatic cancer ( 1% ) and bladder ( 0.
8% ) increased; while Rates of esophageal cancer ( 3.
9% ), stomach cancer ( 3.
0% ), and liver cancer ( 2.
2% ) declined; lung cancer trends remained stable between 2000 and 2016 .
Among women, age-standardized incidence rates increased significantly for thyroid ( 17.
7% ), cervical ( 8.
5% ), uterine ( 3.
5% ), colon ; rectal ( 1.
2% ), lung ( 2.
1% ) and breast cancers ( 3.
0% ), but esophageal cancer (
6.
4% ), gastric cancer ( 2.
9% ) and liver cancer ( 2.
7% ) showed a downward trend
.

The age-standardized incidence rate for all cancers in men remained stable between 2000 and 2016 , but increased significantly by 2.
3% per year in women
.
Among men, increased rates of prostate cancer ( 7.
1% ), colorectal cancer ( 2.
4% ), leukemia ( 1.
9% ), brain cancer ( 1.
5% ), pancreatic cancer ( 1% pancreatic cancer ) and bladder ( 0.
8% ) while the incidence of esophageal cancer ( 3.
9% ), stomach cancer ( 3.
0% ) and liver cancer ( 2.
2% ) decreased; lung cancer trends remained stable between 2000 and 2016 .
Among women, age-standardized incidence rates increased significantly for thyroid cancer ( 17.
7% ), cervical cancer ( 8.
5% ), uterine cancer ( 3.
5% ), colon cancer ; rectal cancer ( 1.
2% colon cancer ), lung cancer ( 2.
1% ) and Breast cancer ( 3.
0%
), but there was a downward trend in esophageal cancer ( 6.
4% ), stomach cancer ( 2.
9% ) and liver cancer ( 2.
7% ) .

Overall cancer mortality declined by 1.
2% per year in men , mainly due to declines in esophageal ( 4.
1% ), stomach ( 3.
4% ), liver ( 2.
7% ) and lung ( 0.
6% ); however, prostate cancer (4.
6 %) %) , colorectal cancer (1.
3%), and pancreatic cancer (1.
0%) increased year by year
.
Mortality rates for other cancers such as bladder, brain and leukemia remained stable
.
Among women, mortality rates for cervical, thyroid, and breast cancers trended upward, while esophagus, stomach, liver, and lung cancers showed a trend of decline
.

Overall cancer mortality declined by 1.
2% per year in men , mainly due to declines in esophageal ( 4.
1% ), stomach ( 3.
4% ), liver ( 2.
7% ) and lung ( 0.
6% ); however, prostate cancer (4.
6 %) %) , colorectal cancer (1.
3%), and pancreatic cancer (1.
0%) increased year by year
.
Mortality rates for other cancers such as bladder, brain and leukemia remained stable
.
Among women, mortality rates for cervical, thyroid, and breast cancers trended upward, while esophagus, stomach, liver, and lung cancers showed a trend of decline
.

in conclusion

conclusion conclusion

The cancer burden in China is high and is expected to continue to increase over the next decade
.
China has issued a series of health policies to prioritize cancer prevention and control
.
This study shows that the continuous increase in the burden of cancer in China is mainly due to the aging population, but after adjusting the age structure of the population, the change trend of each cancer site is different, some show an upward trend, some show a downward trend or remain stable, but digestive system cancer Both the morbidity and mortality showed a downward trend, indicating that the current prevention and control measures in China have played a positive role, especially in this study, which was the first to observe a significant decrease in cancer mortality
.
Cancer prevention and treatment should not only continue to maintain the existing strategies of targeted prevention, early detection, treatment plans, etc.
to control the increasing cancer burden, but also increase investment in cancer clinical treatment and basic research, speed up the anti-cancer process, and improve cancer in China.
survival rate
.

The cancer burden in China is high and is expected to continue to increase over the next decade
.
China has issued a series of health policies to prioritize cancer prevention and control
.
This study shows that the continuous increase in the burden of cancer in China is mainly due to the aging population, but after adjusting the age structure of the population, the change trend of each cancer site is different, some show an upward trend, some show a downward trend or remain stable, but digestive system cancer Both the morbidity and mortality showed a downward trend, indicating that the current prevention and control measures in China have played a positive role, especially in this study, which was the first to observe a significant decrease in cancer mortality
.
Cancer prevention and treatment should not only continue to maintain the existing strategies of targeted prevention, early detection, treatment plans, etc.
to control the increasing cancer burden, but also increase investment in cancer clinical treatment and basic research, speed up the anti-cancer process, and improve cancer in China.
survival rate
.

Note: Journal of the National Cancer Center ( JNCC ) is a fully open-access, peer-reviewed journal in English, hosted by the National Cancer Center
.
It publishes original manuscripts describing research findings in all areas related to cancer, articles such as related news items, reviews, brief communications, and features
.
JNCC employs an efficient process for rigorous and expedited review of submitted manuscripts for timely publication of findings of significant scientific impact with minimal delays
.
The JNCC encourages the submission of randomized controlled clinical trials and will expedite review of such manuscripts
.
The latest editor-in-chief of JNCC is held by Academician Hejie
.

Note: Journal of the National Cancer Center ( JNCC ) is a fully open-access, peer-reviewed journal in English, hosted by the National Cancer Center
.
It publishes original manuscripts describing research findings in all areas related to cancer, articles such as related news items, reviews, brief communications, and features
.
JNCC employs an efficient process for rigorous and expedited review of submitted manuscripts for timely publication of findings of significant scientific impact with minimal delays
.
The JNCC encourages the submission of randomized controlled clinical trials and will expedite review of such manuscripts
.
The latest editor-in-chief of JNCC is held by Academician Hejie
.

Reference News:

Reference News:

https:// class="s1">https:// class="p2">https:// class="s1">https:// Leave a comment here